Lattulosio [Italian]

Lattulosio [Italian] Brand names, Lattulosio [Italian] Analogs

Lattulosio [Italian] Brand Names Mixture

No information avaliable

Lattulosio [Italian] Chemical_Formula

C₂₆H₂₉FN₂O₂

Lattulosio [Italian] RX_link

http://www.rxlist.com/cgi/generic2/livostin.htm

Lattulosio [Italian] fda sheet

Lattulosio [Italian] msds (material safety sheet)

Lattulosio [Italian] Synthesis Reference

No information avaliable

Lattulosio [Italian] Molecular Weight

420.519 g/mol

Lattulosio [Italian] Melting Point

No information avaliable

Lattulosio [Italian] H₂O Solubility

>0.5 mg/mL

Lattulosio [Italian] State

Solid

Lattulosio [Italian] LogP

6.3

Lattulosio [Italian] Dosage Forms

Drops; Spray

Lattulosio [Italian] Indication

As an ophthalmic for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis. Also used as a nasal spray for allergic rhinitis.

Lattulosio [Italian] Pharmacology

Levocabastine is a selective histamine H1-receptor antagonist exerting inhibitory effects on the release of chemical mediators from mast cells and on the chemotaxis of polymorphonuclear leukocytes and eosinophils. Both histamine and antigens induced conjunctivitis can be inhibited by levocabastine. Levocabastine can also reduce symptoms of allergic rhinitis by preventing an increase in vascular permeability of nasal mucosa.

Lattulosio [Italian] Absorption

After instillation in the eye, levocabastine is systemically absorbed, albeit at low levels.

Lattulosio [Italian] side effects and Toxicity

Adverse effects include visual disturbances, dry mouth, cough, nausea, eyelid edema and lacrimation.

Lattulosio [Italian] Patient Information

Lattulosio [Italian] Organisms Affected

Humans and other mammals